View in EDS HTML Full Text PDF Full Text

FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models.

Saved in:
Bibliographic Details
Title: FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models.
Authors: O'Farrell, Marie1 (AUTHOR) marie.ofarrell@sagimet.com, Duke, Greg1 (AUTHOR), Crowley, Richard1 (AUTHOR), Buckley, Douglas1 (AUTHOR), Martins, Eduardo B.1 (AUTHOR), Bhattacharya, Dipankar2 (AUTHOR), Friedman, Scott L.2 (AUTHOR), Kemble, George1 (AUTHOR)
Source: Scientific Reports. 9/19/2022, Vol. 12 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20452322
DOI:10.1038/s41598-022-19459-z